Paris, France
March 13 - March 14, 2009
Recent findings have provided new insights on the pathophysiology of Multiple Sclerosis and on the role of the immune system in this disease. The aim of this annual edition of the Serono Symposia International Foundation conference in MS is to provide an update on these topics and to review the effects of available as well as future therapies on these mechanisms which offer the opportunity to individualize treatment. An overview on the neuroprotection approach will also be covered.
LEARNING OBJECTIVES
The main objectives of the conference are to:
- Present known and most recently observed pathophysiological mechanisms;
- Review the effects of available as well as future treatments on the onset and evolution of MS;
- Provide a focus on neuroprotection in terms of mechanisms, diagnosis and pharmacologic manipulation;
- Propose how to tailor MS treatment with available treatments;
- Point out future options to further individualize treatment.
TARGET AUDIENCE
Clinicians involved in MS patient management and scientists involved in pathophysiological studies.
Serono Symposia International Foundation (www.seronosymposia.org) will submit this program 'Multiple Sclerosis: translating pathophysiology into clinical practice' (Paris, March 13-14 2009) for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME), the Royal College of Physicians and the Italian Ministry of Health.
